Tilray Aktie

Tilray für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2JQSC / ISIN: US88688T1007

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
27.03.2025 22:50:11

Why Investors Were High on Tilray Stock Today

Anytime a company within the chronically struggling marijuana industry sees a leap in stock price, it's notable. That happened on Thursday with top Canadian cannabis company Tilray Brands (NASDAQ: TLRY), following news of a development in the legal sphere. Tilray's shares enjoyed a 9% pop on this news, comparing most favorably to the 0.3% slump of the S&P 500 index that day.Just after market hours on Wednesday, Tilray announced -- no doubt with relief -- that a lawsuit against the company had been dismissed in a Massachusetts court. In the suit, a plaintiff named Clement Italume accused Tilray and Hexo (a peer Canadian marijuana company it acquired in mid-2023) of failing to properly disclose and notify shareholders of certain Hexo actions. Italume also alleged that those investors were not properly informed of the acquisition. Finally, he accused Hexo of engineering a 2020 reverse stock split in order to essentially harm shareholders. Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Tilray (ex Aphria)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Tilray (ex Aphria) 0,59 -4,15% Tilray (ex Aphria)